Spots Global Cancer Trial Database for A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
Official Title: A Phase II Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
Study ID: NCT03026803
Study Description
Brief Summary: This phase II trial is studying how well giving oxaliplatin and capecitabine together works in treating patients with liver cancer.
Detailed Description: Drugs used in chemotherapy, such as oxaliplatin and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving these drugs together may kill more tumor cells.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope Medical Center, Duarte, California, United States
Contact Details
Name: Yun Yen, MD
Affiliation: City of Hope Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
